Thyrocare deal completes our diagnostics play: PharmEasy’s parent co

After closing the deal in Navi Mumbai on Friday evening, API Holdings CEO Siddharth Shah told TOI, “With Thyrocare, we will offer a holistic platform to the consumer for the entire outpatient healthcare — including consultations, diagnostic tests and treatment. In PharmEasy, we have about 80,000 pharmacies and 6,000 doctors, and only the diagnostics play was missing, which has now been completed with this deal.” API is the parent company of digital healthcare firm PharmEasy, founded by Dharmil Sheth, Dhaval Shah, Harsh Parekh, Hardik Dedhia and Siddharth Shah.

The latest deal, in the making for over a month, was struck at 30x ebitda. “Over the last year, we have created our diagnostics business worth Rs 75 crore, and wanted to build on it.